v3.26.1
Fair Value Measurements (Tables)
 3 Months Ended
May 02, 2026
Fair Value Disclosures [Abstract]  
Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis

The following table presents financial instruments that are measured at fair value on a recurring basis at May 2, 2026, January 31, 2026 and May 3, 2025:

 

 

 

Fair Value Measurements

 

(In thousands)

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

As of May 2, 2026

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents - money market mutual funds

 

$

101,610

 

 

$

0

 

 

$

0

 

 

$

101,610

 

Marketable securities - mutual funds that fund
    deferred compensation

 

 

13,248

 

 

 

0

 

 

 

0

 

 

 

13,248

 

Total

 

$

114,858

 

 

$

0

 

 

$

0

 

 

$

114,858

 

As of January 31, 2026

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents - money market mutual funds

 

$

109,149

 

 

$

0

 

 

$

0

 

 

$

109,149

 

Marketable securities - mutual funds that fund
    deferred compensation

 

 

13,636

 

 

 

0

 

 

 

0

 

 

 

13,636

 

Total

 

$

122,785

 

 

$

0

 

 

$

0

 

 

$

122,785

 

As of May 3, 2025

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents - money market mutual funds

 

$

68,330

 

 

$

0

 

 

$

0

 

 

$

68,330

 

Marketable securities - mutual funds that fund
    deferred compensation

 

 

14,477

 

 

 

0

 

 

 

0

 

 

 

14,477

 

Total

 

$

82,807

 

 

$

0

 

 

$

0

 

 

$

82,807

 
Schedule of Liabilities Measure at Fair Value on Recurring Basis

The following table presents liabilities that are measured at fair value on a recurring basis at May 2, 2026, January 31, 2026 and May 3, 2025:

 

 

 

Fair Value Measurements

 

(In thousands)

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

As of May 2, 2026

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration

 

$

0

 

 

$

0

 

 

$

459

 

 

$

459

 

Total

 

$

0

 

 

$

0

 

 

$

459

 

 

$

459

 

As of January 31, 2026

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration

 

$

0

 

 

$

0

 

 

$

451

 

 

$

451

 

Total

 

$

0

 

 

$

0

 

 

$

451

 

 

$

451

 

As of May 3, 2025

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration

 

$

0

 

 

$

0

 

 

$

401

 

 

$

401

 

Total

 

$

0

 

 

$

0

 

 

$

401

 

 

$

401

 
Schedule of Deferred Compensation Plan Liabilities and Related Marketable Securities

The following tables present the balances and activity of the Company’s deferred compensation plan liabilities and related Marketable Securities:

 

(In thousands)

 

May 2, 2026

 

 

January 31, 2026

 

 

May 3, 2025

 

Deferred compensation plan current liabilities

 

$

206

 

 

$

1,235

 

 

$

4,266

 

Deferred compensation plan long-term liabilities

 

 

12,682

 

 

 

12,114

 

 

 

9,539

 

Total deferred compensation plan liabilities

 

$

12,888

 

 

$

13,349

 

 

$

13,805

 

Marketable securities - mutual funds that fund deferred compensation

 

$

13,248

 

 

$

13,636

 

 

$

14,477

 

 

(In thousands)

 

Thirteen
Weeks Ended
 May 2, 2026

 

 

Thirteen
Weeks Ended
 May 3, 2025

 

Deferred compensation liabilities

 

 

 

 

 

 

   Employer contributions, net

 

$

111

 

 

$

114

 

   Investment earnings (losses)

 

 

220

 

 

 

(436

)

Marketable Securities

 

 

 

 

 

 

Mark-to-market (gains) losses (1)

 

 

(211

)

 

 

605

 

Net deferred compensation expense

 

$

120

 

 

$

283

 

(1) Included in the mark-to-market activity related to equity securities still held at quarter-end, we recognized an unrealized gain of $116,000 and an unrealized loss of $94,000 for the thirteen weeks ended May 2, 2026 and May 3, 2025, respectively.